News, Deals & Cases

On 7 August 2026, UBS AG, acting through its Stamford branch, successfully completed its issuance of USD 1.25 billion in aggregate principal amount of 5.053% Fixed-to-Floating Rate Senior Notes due 2032 and USD 750 million Floating Rate Senior Notes due 2029 under its medium-term notes program. The notes were offered and sold in reliance on (i) an exemption from registration provided by Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and (ii) Section 16.6 of Part 16 of the regulations of the Office of the Comptroller of the Currency.

On 27 July 2026, Cembra Monday Bank AG successfully raised CHF 52 million in equity through an accelerated bookbuilding process by placing 601‘801 treasury shares. The net proceeds from the offering are expected to partly finance the acquisition price of the substantial part of Santander‘s Swiss auto financing business.

On 20 July 2026, PolyPeptide Group AG (SIX: PPGN), a specialized global Contract Development & Manufacturing Organization (CDMO) for peptide-based active pharmaceutical ingredients, and Samsung Biologics Co., Ltd. announced that they have entered into a transaction agreement under which Samsung Biologics agreed to make an all-cash public tender offer to acquire all publicly held registered shares of PolyPeptide for CHF 44.31 per share. The offer values PolyPeptide‘s equity at approximately CHF 1.46 billion. Samsung Biologics published its pre-announcement of the offer today. PolyPeptide‘s largest individual shareholder, owning a stake of approximately 55.65% (excluding treasury shares), has committed to tender all…

On 6 July 2026, Salt, a Swiss telecommunications provider, launched a comprehensive refinancing which consisted of (i) a high yield bond offering of CHF 205 million aggregate principal amount of 2.500% senior secured notes due 2031, (ii) the repricing of a new EUR 855 million term loan facility B4 and (iii) a private placement of EUR 30 million aggregate principal amount of 4.500% senior secured notes due 2030. The notes were issued by NJJ Continental S.A. and guaranteed by NJJ Continental Holding S.A. as well as Salt Mobile SA. The CHF denominated notes are expected to be admitted to trading…

On 2 July 2026, UBS Group AG successfully completed its issuance of JPY 65.6 billion in aggregate principal amount of 2.362 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due July 2030, JPY 35.6 billion in aggregate principal amount of 2.759 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due July 2032, and JPY 8.8 billion in aggregate principal amount of 3.427 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due July 2037 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG‘s Swiss gone concern capital requirement. The Notes are governed by…

On 2 July 2026, Monitchem Holdco 3 S.A. successfully completed its issuance of EUR 625 million 8.00 per cent. Senior Secured Notes due 2031. The Notes are guaranteed by various subsidiaries of the issuer, including CABB AG. The Notes are governed by New York law and are listed on the Official List of The International Stock Exchange.

On 9 July 2026, Infracore SA, Switzerland‘s leading specialist in healthcare real estate, successfully completed its initial public offering on SIX Swiss Exchange. Priced at CHF 54 per share, the IPO consisted of 4,209,203 firm shares, comprising 3,703,703 newly issued shares and 505,500 existing shares sold by Infracore‘s largest shareholder, MPT Switzerland Holdings S.à r.l., and an over-allotment option of up to 420,920 existing shares granted by MPT, exercisable on or before 8 August 2026. Trading in the shares on SIX started on 9 July 2026. Based on the offer price of CHF 54 per share, the aggregate offer size (assuming the over-allotment option is exercised in…

On 19 June 2026, SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, closed its underwritten public offering with total gross proceeds of USD 57.5 million. TD Cowen acted as the lead book-running manager for the offering. Guggenheim Securities acted as book-running manager, and BTIG and Craig-Hallum acted as lead managers for the offering.

On 17 June 2026, Zürcher Kantonalbank successfully completed a further offering of Bail-in Bonds in the amount of EUR 500 million with a fixed annual coupon of 3.622% (6NC5 structure). The Bail-in Bonds have been designed and issued on the basis of a legal framework allowing Cantonal Banks to issue Total-Loss-Absorbing-Capacity (Gone-Concern Capital). BNP PARIBAS, Commerzbank Aktiengesellschaft, UBS London Branch and Zürcher Kantonalbank acted as Joint Lead Managers.